IPO Financial News

DOMS Industries, a leading player in stationery and art products, has filed its draft red herring prospectus with the market regulator Securities and Exchange Board of India (Sebi), to raise up to ₹1,200 from an initial public offering (IPO). The proposed IPO comprises a fresh issue aggregating up to ₹350 crore and an offer for sale of up to ₹850 crore from existing investors.

₹29.42 crore of the IPO proceeds. “The question which arises for consideration is, that once an AO, after making an inquiry and adjudicating the matter quashes the proceedings, is it open to an another authority of Sebi to adjudicate the same issue on the same facts under Section 11 and 11B of the Sebi Act and pass contradictory orders," the Securities Appellate Tribunal (SAT) asked in a 12 April order. SAT also criticized Sebi for not following a consistent approach and observed that the orders of an AO will be binding on Sebi in such cases.

₹1,200 crore of the leading holistic creative products player in the Indian stationery and art products market comprises a fresh issue aggregating up to ₹350 crore and an offer for sale (OFS) aggregating up to ₹850 crore. The offer for sale comprises of equity shares aggregating up to ₹800 crore million by corporate promoter, F.I.L.A.

Investing.com -- Chip designer Arm announces plans for a much-anticipated initial public offering, although the Softbank-owned group stops short of specifying its valuation. Elsewhere, tech stocks remain resilient in the face of surging bond yields as excitement for Nvidia's latest quarterly earnings report grows, while Microsoft restructures its mega-merger with Activision Blizzard to appease U.K. regulators.

₹75 per equity share of face value of ₹10 each. Bids can be made for a minimum of 1,600 equity shares and in multiples of 1,600 equity shares thereafter. Bondada Engineering IPO issue price is 7.5 times the face value of the equity share.

reality for thousands of European startups, many of which have had to scale back expansion plans as venture-capital funding plunges following sluggish economic growth and rising interest rates. Improved returns now offered by bonds and other relatively safe investments have drawn many European investors away from riskier, less familiar asset classes such as startups. Venture-capital funding has dropped significantly in the U.S.

ChatGPT, has pushed any stock vaguely related to AI up this year. The coming initial public offering of British chip designer Arm will put this market frenzy—and its parent SoftBank’s own AI ambitions—to the test. Riding on the AI wave, Arm, which has filed to go public on the Nasdaq exchange next month, could be the largest new listing this year.

₹98 crore ahead of its initial public offer (IPO). The fintech has undertaken a pre-IPO placement of 5,975,609 equity shares at a price of Rs. 164 per equity share (including a share premium of Rs.

On day 2, Crop Life Science IPO Subscription Status was 2.36 time, and on day 1 the issue was subscribed 84%. Also Read: Pyramid Tecnoplast IPO: What GMP, subscription status signal on last date of bidding Crop Life Science Limited IPO GMP today or grey market premium is -4. This indicates that the shares of Crop Life Science IPO GMP were trading at a discount of ₹4 in the grey market on Tuesday, according to topsharebrokers.com.

TVS Supply Chain Solutions will likely debut on the exchanges on August 23. Ahead of the listing, the company's shares are fetching a mild premium of Rs 4 in the unlisted market, indicating a muted listing on the Street. Considering the upper price band of Rs 197, the stock is expected to debut at a premium of just 2% over the issue price. However, it is important to note that grey market premiums are just an indicator as to how the company's shares are stacked up in the unlisted market and are subject to change rapidly. The IPO was subscribed to 2.85 times overall, which is a decent response.

IPO) of Vishnu Prakash R Punglia will open for subscription on August 24. The issue closes on August 28.

IPO Subscription Status: Pyramid Technoplast IPO was subscribed 18.16 times on day 3, so far. Pyramid Technoplast IPO opened Friday, August 18 and will close today (Tuesday, August 22). Pyramid Technoplast IPO received overwhelming response from non-institutional investors (NIIS) and retail investors on day 3.

Softbank bought a 25% stake in Arm last week that valued it at $64bn, returning money to its Vision Fund and potentially setting a floor for the valuation.

IPO listing: TVS Supply Chain IPO share listing process has begun. The ₹880 crore-worth public issue, which was open from August 10 to August 14, was subscribed 2.85 times in total. TVS Supply Chain IPO share allotment was finalised on August 21, Monday.

The Australian Securities and Investments Commission was investigating Macquarie’s handling of the Nuix IPO when the then treasurer, Josh Frydenberg, appointed its former chief executive Nicholas Moore to lead an independent review into the “effectiveness and capability” of the regulator.

Arm Ltd filed for its initial public offering (IPO) in the US on Monday, in what is likely to be the biggest listing of the year. The company has not disclosed the size of the offering.SoftBank plans to sell about 10% of Arm's shares in the IPO, seeking a valuation of $60-70 billion, Reuters reported.

According to market sources, the company's shares are commanding a premium of Rs 22 in the unlisted market. Most analysts advised investors to subscribe to the issue given the company's diversified customer base along with the comprehensive product portfolio. Pyramid Technoplast is an industrial packaging company engaged in the business of manufacturing polymer-based molded products (Polymer Drums) mainly used by chemical, agrochemical, specialty chemical, and pharmaceutical companies for their packaging requirements. The IPO comprises a fresh issue of 55 lakh shares and an offer for sale of 37.2 lakh shares.

IPO Subscription Status: The initial public offering (IPO) of Ashish Kacholia-backed company Aeroflex Industries Ltd opened for public subscription today, August 22. The public issue, which will remain open for bidding till August 24, has received stellar response from investors as the issue got fully subscribed within hours of opening. Aeroflex Industries IPO has been subscribed 2.88 times so far on day 1 as the issue received bids for 6.69 crore equity share as compared to 3.25 crore shares on the offer, till 1:00 pm.

IPO. It received Sebi's observation letter on August 11, an update with the regulator showed on Tuesday. The company issued 16.7 lakh shares at a price of Rs 735 apiece, according to a public announcement. Investors participated in the pre-IPO round include SBI Magnum Children's Benefit Fund, SBI Optimal Equity Fund, SBI Healthcare Opportunities Fund, Neuberger Berman Emerging Markets Equity Fund, Neuberger Berman Europe Holdings LLC and Neuberger Berman Strategic India Equity Master Fund Holdings Ltd. In addition, High Conviction Fund — Series 1, Ashoka India Equity Investment Trust PLC, Think India Opportunities Master Fund LP and DC Ikka Ltd too participated. In May, Jupiter filed its preliminary papers with the market regulator Sebi to raise funds through an IPO. The issue consists of a fresh issue of equity shares worth up to Rs 615 crore and an offer-for-sale (OFS) of up to 44.5 lakh equity shares by promoter group and other selling shareholders. With the completion of the pre-IPO placement, the fresh issue size will now be reduced. Proceeds from the maiden public issue will be utilised for payment of debt and general corporate purposes. The hospital chain operates in Thane, Pune and Indore under the Jupiter brand with a total bed capacity of 1,194 as of December 2022.Jupiter Hospitals, which has a strategic focus on the Western India healthcare market, is in the process of developing a multispecialty hospital in Dombivli, Maharashtra, being designed to accommodate over 500 beds. After making a loss in the financial year 2020-21, the company reported a profit of Rs 51.13 crore in 2021-22. Its revenue from operations jumped 51 per cent to Rs 733.12 crore in FY22 from Rs 486.16 crore in FY21. For the nine months

₹123 crore in its pre-IPO placement. The company has issued around 16.7 lakh shares at a price of ₹735 apiece to the investors. The company saw participation from institutional investors, including SBI Magnum Children’s Benefit Fund, SBI Optimal Equity Fund, and SBI Healthcare Opportunities Fund, Neuberger Berman Emerging Markets Equity Fund, Neuberger Berman Europe Holdings LLC, and Neuberger Berman Strategic India Equity Master Fund Holdings Limited, High Conviction Fund - Series 1, Ashoka India Equity Investment Trust PLC, Think India Opportunities Master Fund LP, DC Ikka Ltd.

₹900 crore from the primary market and has filed preliminary papers for its maiden public issue. The Vadodara-based Shiva Pharmachem has filed its Draft Red Herring prospectus (DRHP) with capital market regulator Securities & Exchange Board of India (SEBI) for an initial public offering (IPO). Shiva Pharmachem IPO is entirely an offer for sale (OFS) of up to ₹900 crore by the promoter and promoter group shareholders.